If Poteligeo Isn't Approved by UnitedHealthcare in Virginia: Formulary Alternatives & Exception Paths
Answer Box
If UnitedHealthcare denies Poteligeo (mogamulizumab-kpkc) for mycosis fungoides or Sézary syndrome in Virginia, you have two paths: try required formulary alternatives first (romidepsin, vorinostat, brentuximab vedotin) or request a step therapy exception with strong clinical documentation. If denied, Virginia's Bureau of Insurance offers external review within